Scinovex
article Open AccessTop 1% cited

Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition

PLoS Biology · 2008 · Vol. 6(10) · pp. e253–e253
José SilvaOrnella BarrandonJennifer NicholsJitsutaro KawaguchiThorold W. TheunissenAustin Smith

Abstract

Induced pluripotent stem (iPS) cells are generated from somatic cells by genetic manipulation. Reprogramming entails multiple transgene integrations and occurs apparently stochastically in rare cells over many days. Tissue stem cells may be subject to less-stringent epigenetic restrictions than other cells and might therefore be more amenable to deprogramming. We report that brain-derived neural stem (NS) cells acquire undifferentiated morphology rapidly and at high frequency after a single round of transduction with reprogramming factors. However, critical attributes of true pluripotency--including stable expression of endogenous Oct4 and Nanog, epigenetic erasure of X chromosome silencing in female cells, and ability to colonise chimaeras--were not attained. We therefore applied molecularly defined conditions for the derivation and propagation of authentic pluripotent stem cells from embryos. We combined dual inhibition (2i) of mitogen-activated protein kinase signalling and glycogen synthase kinase-3 (GSK3) with the self-renewal cytokine leukaemia inhibitory factor (LIF). The 2i/LIF condition induced stable up-regulation of Oct4 and Nanog, reactivation of the X chromosome, transgene silencing, and competence for somatic and germline chimaerism. Using 2i /LIF, NS cell reprogramming required only 1-2 integrations of each transgene. Furthermore, transduction with Sox2 and c-Myc is dispensable, and Oct4 and Klf4 are sufficient to convert NS cells into chimaera-forming iPS cells. These findings demonstrate that somatic cell state influences requirements for reprogramming and delineate two phases in the process. The ability to capture pre-pluripotent cells that can advance to ground state pluripotency simply and with high efficiency opens a door to molecular dissection of this remarkable phenomenon.

Pluripotent Stem Cells ResearchCRISPR and Genetic EngineeringRenal and related cancersBiologyReprogrammingInduced pluripotent stem cellHomeobox protein NANOGCell biologySOX2Stem cellKLF4Cell potencySomatic cell

MeSH terms

Kruppel-Like Factor 4AnimalsBrainCells, CulturedFemaleFlow CytometryFluorescent Antibody TechniqueNeuronsBlotting, NorthernSignal TransductionIn Situ Hybridization, FluorescenceReverse Transcriptase Polymerase Chain ReactionPluripotent Stem CellsMiceCellular Reprogramming

Funding

  • Wellcome Trust
  • University of Cambridge
  • European Commission
  • Directorate for Biological Sciences
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council
Citations
831
FWCI
31.31
field-weighted impact
References
38
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.